GSK-3β as a target for protection against transient cerebral ischemia

Stroke remains the leading cause of death and disability worldwide. This fact highlights the need to search for potential drug targets that can reduce stroke-related brain damage. We showed recently that a glycogen synthase kinase-3β (GSK-3β) inhibitor attenuates tissue plasminogen activator-induced...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Med Sci
Huvudupphovsmän: Wang, Wei, Li, Mingchang, Wang, Yuefei, Wang, Zhongyu, Zhang, Wei, Guan, Fangxia, Chen, Qianxue, Wang, Jian
Materialtyp: Artigo
Språk:Inglês
Publicerad: Ivyspring International Publisher 2017
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5436475/
https://ncbi.nlm.nih.gov/pubmed/28553165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.17514
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk